The European Union Drugs Agency (EUDA) today released its Consolidated Annual Activity Report 2025, capturing the agency’s key achievements, governance activities and organisational developments during the first full year of operation under its expanded mandate.Structured around three core areas — health, security and business transformation — the report outlines how the EUDA…
Čtěte více
This week, the European Union Drugs Agency (EUDA) hosted a technical meeting on Drug market-related violence in Europe: current situation, monitoring and responses, bringing together experts from across Europe to examine one of the most pressing security challenges linked to illicit drug markets today.Drug market-related violence has become an increasing concern in parts of Europe, fuelled by competition between criminal networks involved in the production, trafficking and distribution of illicit drugs. While the nature and intensity of this violence vary across countries, its…
Čtěte více
People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This warning comes from the European Union Drugs Agency (EUDA) in its European Drug Report 2026: Trends and Developments, released today (1).
Based on data from 29 countries (EU-27, Norway and Türkiye), the annual review highlights risks to public health posed by the wide availability and use of an increasingly diverse range of substances, often of high potency or purity. New cannabis products continue to appear, while the variety of opioids and stimulants sold is on the rise.…
Čtěte více
